Search

Your search keyword '"Claudio N."' showing total 593 results

Search Constraints

Start Over You searched for: Author "Claudio N." Remove constraint Author: "Claudio N." Search Limiters Full Text Remove constraint Search Limiters: Full Text
593 results on '"Claudio N."'

Search Results

1. Modulation of neural oscillations in escitalopram treatment: a Canadian biomarker integration network in depression study

2. Personalized relapse prediction in patients with major depressive disorder using digital biomarkers

3. A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study

4. Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study

6. Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study

7. Adaptación transcultural al español rioplatense de la escala 'Telemedicine Satisfaction and Usefulness Questionnaire' y evaluación del nivel de satisfacción global de la Tele-Rehabilitación en un Servicio de Kinesiología y Terapia Ocupacional

8. How good are AlphaFold models for docking-based virtual screening?

10. Phylogenomics reveals viral sources, transmission, and potential superinfection in early-stage COVID-19 patients in Ontario, Canada

11. GPR56/ADGRG1 is associated with response to antidepressant treatment

12. Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain Disorders

13. A Machine Learning Model to Predict Drug Transfer Across the Human Placenta Barrier

15. Variación estacional de aves en el humedal de Trumao, centro-sur de Chile

16. High-Throughput Docking Using Quantum Mechanical Scoring

17. MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes

19. Insulin Resistance as a Shared Pathogenic Mechanism Between Depression and Type 2 Diabetes

20. Quantum Chemical Approaches in Structure-Based Virtual Screening and Lead Optimization

21. Discovery of Novel Bovine Viral Diarrhea Inhibitors Using Structure-Based Virtual Screening on the Envelope Protein E2

23. Modulation of neural oscillations in escitalopram treatment: a Canadian biomarker integration network in depression study

24. Electronic Mechanisms of Intra and Intermolecular J Couplings in Systems with C-H···O Interactions

25. COMPARAÇÃO ENTRE POPULAÇÕES, CRUZAMENTOS INTERPOPULACIONAIS E HÍBRIDOS COMERCIAIS DE MILHO

27. A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study

31. Full genome analysis of microglial activation : ramifications of TREM2

32. Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study

33. Using biodiversity databases to assess vascular plant diversity in Protected Areas: a case study of Parque Estadual do Forno Grande, Brazil.

34. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes

40. Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report

41. Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report

42. The canonical equilibrium of constrained molecular models

43. An exact expression to calculate the derivatives of position-dependent observables in molecular simulations with flexible constraints

44. Influence of CYP2C19 , CYP2D6 , and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study.

45. Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study

46. Developing an Electroencephalography-Based Model for Predicting Response to Antidepressant Medication

47. The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocols

49. Influence of CYP2C19, CYP2D6, and ABCB1Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study

50. GPR56/ADGRG1 is associated with response to antidepressant treatment

Catalog

Books, media, physical & digital resources